KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Others

ClearPoint Neuro (CLPT) Short term Debt (2017 - 2020)

ClearPoint Neuro's Short term Debt history spans 7 years, with the latest figure at $73985.0 for Q3 2020.

On a quarterly basis, Short term Debt changed N/A to $73985.0 in Q3 2020 year-over-year; TTM through Sep 2020 was $73985.0, a N/A change, with the full-year FY2017 number at $95786.0, changed N/A from a year prior.
Short term Debt hit $73985.0 in Q3 2020 for ClearPoint Neuro, down from $296677.0 in the prior quarter.
Over the last five years, Short term Debt for CLPT hit a ceiling of $296677.0 in Q2 2020 and a floor of $22295.0 in Q2 2018.
Historically, Short term Debt has averaged $103723.6 across 3 years, with a median of $73985.0 in 2020.